P1.02-021 Review of Clinical Outcomes Attributable to Next Generation Sequencing Based Broad Mutation Panel Testing in Lung Adenocarcinoma

Cathal OBrien; Kathleen Brosnan; Sinead Cuffe; Stephen Finn

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P1.02-021 Review of Clinical Outcomes Attributable to Next Generation Sequencing Based Broad Mutation Panel Testing in Lung Adenocarcinoma

【24h】

P1.02-021 Review of Clinical Outcomes Attributable to Next Generation Sequencing Based Broad Mutation Panel Testing in Lung Adenocarcinoma

机译：P1.02-021临床结果涉及下一代测序基于肺腺癌的广泛突变面板测试的临床结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
作者
Cathal OBrien; Kathleen Brosnan; Sinead Cuffe; Stephen Finn;
展开▼
作者单位

Cancer Molecular Diagnostics St James’ Hospital;

Dept of Histopathology St James’ Hospital;

Dept of Medical Oncology St James’ Hospital;

Dept of Histopathology St James’ Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P1.02-021 Review of Clinical Outcomes Attributable to Next Generation Sequencing Based Broad Mutation Panel Testing in Lung Adenocarcinoma [J] . Cathal OBrien, Kathleen Brosnan, Sinead Cuffe, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P1.02-021临床结果涉及下一代测序基于肺腺癌的广泛突变面板测试的临床结果
2. Clinical characteristics and treatment outcomes of lung adenocarcinomas with discrepant EGFR mutation testing results derived from PCR-direct sequencing and real-time PCR-based assays [J] . ChiuC.-H., HoH.-L., ChiangC.-L., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2014,第1期

机译：从PCR直接测序和基于实时PCR的检测得出的EGFR突变检测结果不一致的肺腺癌的临床特征和治疗结果
3. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches [J] . Drilon Alexander, Wang Lu, Arcila Maria E., Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第16期

机译：广泛的，基于混合捕获的下一代测序技术可确定肺腺癌中可操作的基因组改变，否则通过其他基因组测试方法对此类改变不利
4. Sentosa SQ Leukemia Panel: Development of Targeted Next Generation Sequencing IVD Test for Detecting Mutations in Leukemia Patients [C] . Atreyee Saha, Pramila Ariyaratne, Wen Huang, International Molecular Medicine Tri-Conference. . 2016

机译：Sentosa Sq白血病面板：靶向下一代测序IVD试验检测白血病患者突变的研究
5. Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification [O] . Yanna Cao, Yan Jin, Jinpu Yu, 2017

机译：新一代测序技术对MYCN扩增的神经母细胞瘤体细胞突变进行综合面板检测的临床评估
6. Clinical Characteristics and Treatment Outcomes of Lung Adenocarcinomas with Discrepant EGFR Mutation Testing Results Derived from PCR-Direct Sequencing and Real-Time PCR-Based Assays [O] . Chiu Chao-Hua, Ho Hsiang-Ling, Chiang Chi-Lu, 2014

机译：PCR直接测序和实时PCR检测得出的EGFR突变检测结果不一致的肺腺癌的临床特征和治疗结果

P1.02-021 Review of Clinical Outcomes Attributable to Next Generation Sequencing Based Broad Mutation Panel Testing in Lung Adenocarcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅